In the aftermath of COVID-19, Indonesia’s healthcare sector is set to undergo significant changes to keep pace with a rapidly expanding population and increasing healthcare awareness. There is a growing preference for preventive medicine and sophisticated diagnostic services, including esoteric testing. The environment is opportune for disruption by the private sector and offers private capital investors the potential to generate attractive returns over the medium-to-long term.
Read our latest report to find out how private capital stands to play a central role in the transformation of the healthcare market, which are the key companies to watch and what are the challenges and opportunities in play.
